- Preoperative Concurrent Chemoradiotherapy with Oral Fluoropyrimidine in Locally Advanced Rectal Cancer: How Good Is Good Enough?
-
Chung HC
- KMID: 2166123
- Cancer Res Treat.
- 2004 Dec;36(6):341-342.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Proteome Analysis of Differential Protein Expression in Cervical Cancer Cells after Paclitaxel Treatment
-
Yim EK, Bae JS, Lee SB, Lee KH, Kim CJ, Namkoong S, Um SJ, Park JS
- KMID: 2166132
- Cancer Res Treat.
- 2004 Dec;36(6):395-399.
PURPOSE: It is well known that infection with HPV (human papillomavirus) is the main cause of cervical cancer and certain types of HPV are recognized as carcinogens. At present, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Photodynamic Effects of Radachlorin(R) on Cervical Cancer Cells
-
Bae SM, Kim YW, Lee JM, Namkoong S, Han SJ, Kim JK, Lee CH, Chun HJ, Jin HS, Ahn WS
- KMID: 2166131
- Cancer Res Treat.
- 2004 Dec;36(6):389-394.
PURPOSE: Photodynamic therapy (PDT) is a novel treatment modality, which produces local tissue necrosis with laser light following the prior administration of a photosensitizing agent. Radachlorin(R) has recently been shown... -
- CITED
-
- Close
- SHARE
-
- Close
- Responsiveness of CPT-11 in Respect to hMLH1 and hMSH2 Protein Expression in the Primary Colorectal Cancer
-
Park IJ, Kim HC, Yu CS, Chang HM, Lee JH, Kim JH, Kim TW, Kim JS, Kim JC
- KMID: 2166126
- Cancer Res Treat.
- 2004 Dec;36(6):360-366.
PURPOSE: The aim of this study was to evaluate the responsiveness to CPT-11 with respect to hMLH1 and hMSH2 protein expressions in primary colorectal tumors. MATERIAL AND METHODS: 91 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- An Analysis of the Risk Factors and Management of Lymphocele after Pelvic Lymphadenectomy in Patients with Gynecologic Malignancies
-
Kim HY, Kim JW, Kim SH, Kim YT, Kim JH
- KMID: 2166129
- Cancer Res Treat.
- 2004 Dec;36(6):377-383.
OBJECTIVES: The incidence and risk factors of lymphocele development after pelvic lymphadenectomy were evaluated and its management investigated. MATERIALS AND METHODS: This retrospective study was carried out on 264 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Matrix Metalloproteinase-9 Correlates with Poor Prognosis in Human Malignant Fibrous Histiocytoma
-
Yoo J, Jung JH, Kang SJ, Kang CS
- KMID: 2166130
- Cancer Res Treat.
- 2004 Dec;36(6):384-388.
PURPOSE: 92 kDa matrix metalloproteinase-9 (MMP-9) is believed to play an important role in degrading the matrix and basement membrane, contributing to the invasion and metastasis of malignant solid tumors.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy
-
Shin SJ, Kim MK, Lee KH, Hyun MS, Kim SW, Song SK, Bae SH, Ryoo HM
- KMID: 2166127
- Cancer Res Treat.
- 2004 Dec;36(6):367-371.
PURPOSE: This study was conducted to confirm the efficacy and toxicity of docetaxel and cisplatin combination chemotherapy (DP) in patients with advanced gastric cancer. MATERIALS AND METHODS: Patients with measurable... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective Phase II Study of Preoperative Chemoradiation with Capecitabine in Locally Advanced Rectal Cancer
-
Park JH, Kim JH, Ahn SD, Lee SW, Shin SS, Kim JC, Yu CS, Kim HC, Kang YK, Kim TW, Chang HM, Ryu MH, Choi EK
- KMID: 2166125
- Cancer Res Treat.
- 2004 Dec;36(6):354-359.
PURPOSE: Capecitabine is an attractive oral chemotherapeutic agent that has a radiosensitizing effect and tumor-selectivity. This study was performed to evaluate the efficacy and toxicity of preoperative chemoradiation therapy, when... -
- CITED
-
- Close
- SHARE
-
- Close
- HIF-1alpha: a Valid Therapeutic Target for Tumor Therapy
-
Hong SS, Lee H, Kim KW
- KMID: 2166124
- Cancer Res Treat.
- 2004 Dec;36(6):343-353.
Hypoxia plays a major role in the induction of angiogenesis during tumor development. One mechanism by which tumor cells respond to a reduced oxygen level is via the activation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients
-
Kim JS, Baek JY, Park SR, Choi IS, Kim SI, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ, Kim NK
- KMID: 2166128
- Cancer Res Treat.
- 2004 Dec;36(6):372-376.
PURPOSE: The aim of this study is to compare the antiemetic efficacy and tolerability of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed emesis. MATERIAL AND... -
- CITED
-
- Close
- SHARE
-
- Close
